NRC-2694

CAS: 936446-61-6

Ref. 3D-LMB44661

Produktinformation

• Name: NRC-2694

Beschreibung

NRC-2694 is a novel anilino-based oral solid formulation for the treatment of bladder cancer. NRC-2694 is designed to inhibit the growth of cells in the bladder by binding to them and preventing their division. This drug has shown a safety profile in animal studies and has been shown to be active against squamous cell carcinomas in mice. The drug was also tested in vivo with bioavailability data in rats, showing that it is absorbed through the gastrointestinal tract and distributed throughout the body.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 418.49 g/mol
• Formel: C₂₄H₂₆N₄O₃
• Reinheit: Min. 95%